Downstream Processing Featured Articles

1. Identified 115 Proteins That Would Allow Designing New Generation Anti-Cancer Drugs 4/26/2012

   Researchers from the Research Programme on Biomedical Informatics (GRIB) from the IMIM (Hospital del Mar Research Institute) and the Pompeu Fabra University (UPF) have identified 115 proteins in silico (via computer simulation) that could be highly relevant to treat colon-rectal cancer, since they would make it possible to define the strategy to design new generation anti-cancer drugs.

2. Tiny Capsule Effectively Kills Cancer Cells 2/6/2013

   A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment.

3. Studies Put Kibosh On Statins For Breast Cancer Prevention 12/10/2012

   New data from the Women’s Health Initiative dash cold water on the idea that statin therapy reduces breast cancer risk.The updated WHI findings showed no association between prior statin use and breast cancer risk in nearly 155,000 postmenopausal study participants followed prospectively for an average of 10.8 years.

4. Forsyth Scientists Define The Bacteria That Live In The Mouth, Throat, And Gut 9/20/2012

   For the first time, scientists have defined the bacteria that inhabit multiple sites along the healthy human digestive tract in a large number of individuals. To prevent and control bacterial diseases, it is essential to first identify which bacteria are responsible for keeping us in good health.

5. Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System At ASMS 2012 5/21/2012

   Thermo Fisher Scientific Inc., the world leader in serving science, recently announced the Thermo Scientific Exactive Plus system, the company’s latest benchtop liquid chromatography-mass spectrometry (LC-MS) system for high-throughput screening, identification and quantification of compounds in complex matrices.

6. Designer Bacteria May Lead To Better Vaccines 1/15/2013

   Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

7. Vaccine And Antibiotics Stabilized So Refrigeration Is Not Needed 7/10/2012

   Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.

8. Advion Announces Full Integration With Agilent Technologies Liquid Chromatography Systems 12/10/2012

   Advion, Inc., a leading life sciences Systems and Consumables developer, announces that its expression compact mass spectrometer (CMS) is now fully integrated with Agilent Technologies’ full range of HPLC and (U)HPLC liquid chromatography systems.

9. Is There An Enzyme In Your Future? 8/25/1998
   A method for reducing the chemical steps in vitamin C synthesis from six to two underscores the growing importance of enzymes in organic synthesis...
10. Abbott To Collaborate With Astellas In CMV Vaccine Trial 9/7/2012

    Abbott announced today that it has signed an agreement to collaborate with Astellas Pharma Global Development in a Phase 3 clinical trial for ASP0113 (TransVax™), an investigational vaccine licensed from Vical Incorporated for preventing cytomegalovirus (CMV) reactivation in transplant patients.